UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Diabetes (New York, N.Y.), ISSN 0012-1797, 09/2009, Volume 58, Issue 9, pp. 2070 - 2083
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Zinc Transporter 8 | Zinc - metabolism | Diabetes Mellitus, Type 2 - genetics | Humans | Male | Diabetes Mellitus, Type 2 - metabolism | Exocytosis - physiology | Diabetes Mellitus, Type 2 - epidemiology | Insulin-Secreting Cells - metabolism | Cation Transport Proteins - metabolism | Cytoplasmic Granules - metabolism | Gene Expression - physiology | Cation Transport Proteins - genetics | Female | Insulin Secretion | Insulin-Secreting Cells - physiology | Mice, Inbred C57BL | Risk Factors | Mice, Knockout | Polymorphism, Genetic | Insulin - metabolism | Animals | Homeostasis - physiology | Mice | HeLa Cells | Insulin-Secreting Cells - pathology | Blood Glucose - metabolism | Type 2 diabetes | Physiological aspects | Zinc in the body | Development and progression | Genetic aspects | Glucose | Insulin | Health aspects | Dextrose | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer | Original
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 15, pp. 1845 - 1855
heart failure | renal function | diabetes | SGLT2 inhibitor | Diabetes Mellitus, Type 2 - physiopathology | Kidney - drug effects | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Treatment Outcome | Cardiovascular System - drug effects | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - pharmacology | Myocardial infarction | Heart | Renal function | Heart attacks | Clinical trials | Cardiovascular disease | Glucose | Beta blockers | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucose transporter | Heart failure | Cerebral infarction | Medical research | Stroke | Mortality | Diabetes mellitus | Health risks | Patients | Inhibitors | Sodium | Infarction | Diabetes | Cardiovascular diseases | Transporter | Adenosine triphosphatase
Journal Article
Diabetologia, ISSN 0012-186X, 10/2018, Volume 61, Issue 10, pp. 2087 - 2097
GLUTs | Human Physiology | SGLTs | Metabolic Diseases | Internal Medicine | Glucose | Review | Type 2 diabetes mellitus | Gliflozins | Kidney | Proximal tubule | Phlorizin | Inhibitors | Medicine & Public Health | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Glucose Transporter Type 2 - genetics | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Homeostasis | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 1 - physiology | Sodium-Glucose Transporter 1 - genetics | Glycosuria - metabolism | Hypoglycemic Agents - pharmacology | Mice, Knockout | Sodium-Glucose Transporter 2 - physiology | Kidney - metabolism | Animals | Glucose Transporter Type 2 - physiology | Drug Design | HEK293 Cells | Kidney Tubules, Proximal - metabolism | Glucose - metabolism | Mice | Blood Glucose - metabolism | Kidney Tubules - metabolism | Phlorhizin - pharmacology | Sodium-Glucose Transporter 2 - genetics | Type 2 diabetes | Medical colleges | Analysis | Physiological aspects | Hypoglycemic agents | Dextrose | Membrane proteins | Glucose transporter | Urine | Excretion | Intravenous administration | Renal function | Kidneys | Diabetes mellitus | Reabsorption | Sodium | Physiology | Diabetes | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 10/2013, Volume 170, Issue 3, pp. 519 - 531
tofogliflozin | nephropathy | beta‐cell loss | sodium–glucose co‐transporter inhibitor | sodium-glucose co-transporter inhibitor | beta-cell loss | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Kidney - pathology | Diabetic Nephropathies - etiology | Glycated Hemoglobin A - metabolism | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Angiotensin II Type 1 Receptor Blockers - pharmacology | Insulin-Secreting Cells - metabolism | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Time Factors | Female | Albuminuria - metabolism | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Disease Models, Animal | Glucosides - pharmacology | Kidney - drug effects | Sodium-Glucose Transporter 2 - metabolism | Diabetic Nephropathies - metabolism | Losartan - pharmacology | Biomarkers - blood | Albuminuria - prevention & control | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Animals | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Benzhydryl Compounds - pharmacology | Mice | Insulin-Secreting Cells - pathology | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Glucose metabolism | Pancreatic beta cells | Image processing | Blood sugar | Analysis | Angiotensin | Equipment and supplies | Glucose | Diabetes | Sodium | Pancreas | Insulin | Rodents | Index Medicus | Research Papers | sodium–glucose co-transporter inhibitor
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1322 - 1326
kidney | glucose transporters (GLUT) | type 2 diabetes | sodium‐glucose co‐transporters (SGLT) | sodium-glucose co-transporters (SGLT) | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Glycated Hemoglobin A - analysis | Glucose Transporter Type 2 - genetics | Kidney - pathology | Humans | Glucose Transporter Type 1 - metabolism | Male | Diabetes Mellitus, Type 2 - metabolism | RNA, Messenger - metabolism | Glucose Transporter Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Kidney - metabolism | China | Postprandial Period | Adult | Female | Sodium-Glucose Transporter 1 - metabolism | Sodium-Glucose Transporter 2 - genetics | Hypoglycemic Agents - therapeutic use | Reproducibility of Results | Fasting | Kidney - drug effects | Blood Glucose - analysis | Sodium-Glucose Transporter 2 - metabolism | Gene Expression Regulation - drug effects | Diabetes Mellitus, Type 2 - blood | Glucose Transporter Type 1 - genetics | Biopsy | Diabetes Mellitus, Type 2 - pathology | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Diabetics | Hyperglycemia | RNA | Glycosylated hemoglobin | Glucose | Dextrose | Diabetes | Index Medicus
Journal Article
Journal of cellular physiology, ISSN 0021-9541, 12/2007, Volume 213, Issue 3, pp. 834 - 843
Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell Polarity | Glucose Transporter Type 2 - genetics | Glucose Transporter Type 5 - metabolism | Enterocytes - metabolism | Sweetening Agents - metabolism | Humans | RNA, Messenger - metabolism | Fructose - metabolism | Glucose Transporter Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Transfection | Cloning, Molecular | Sucrose - metabolism | Jejunum - cytology | Sodium-Glucose Transporter 1 - metabolism | Monosaccharide Transport Proteins - metabolism | Monosaccharide Transport Proteins - genetics | Oligo-1,6-Glucosidase - genetics | Caco-2 Cells | Protein Structure, Tertiary | Green Fluorescent Proteins - metabolism | Promoter Regions, Genetic | Mice, Inbred C57BL | Hexoses - metabolism | Mice, Knockout | Animals | Glucose Transporter Type 2 - chemistry | Sucrase - genetics | Glucose - metabolism | Mice | Glucose Transporter Type 5 - genetics | Index Medicus | Green Fluorescent Proteins | Sucrose | Glucose | Cellular Biology | Tissues and Organs | Life Sciences | Jejunum | Oligo-1,6-Glucosidase | Sucrase | Food and Nutrition | Hexoses | Glucose Transporter Type 5 | Glucose Transporter Type 2 | Biochemistry, Molecular Biology | Sodium-Glucose Transporter 1 | Fructose | Human health and pathology | Enterocytes | Monosaccharide Transport Proteins | RNA, Messenger | Sweetening Agents
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 06/2017, Volume 101, Issue 6, pp. 763 - 772
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Metformin - therapeutic use | Diabetes Mellitus, Type 2 - genetics | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Organic Cation Transporter 2 | Membrane Transport Proteins - genetics | Symporters | Aged, 80 and over | Pharmacogenomic Variants | Female | Membrane Transport Proteins - metabolism | Databases, Factual | Hypoglycemic Agents - therapeutic use | Organic Cation Transport Proteins - metabolism | Genotype | Treatment Outcome | Octamer Transcription Factor-1 - genetics | Biomarkers - blood | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Phenotype | Aged | Polymorphism, Single Nucleotide | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Organic Cation Transport Proteins - genetics | Octamer Transcription Factor-1 - metabolism | Type 2 diabetes | Analysis | Dosage and administration | Genetic aspects | Research | Metformin | Pharmacokinetics | Drug therapy | Genetic polymorphisms | Index Medicus | Abridged Index Medicus
Journal Article
Metabolism, clinical and experimental, ISSN 0026-0495, 2014, Volume 63, Issue 10, pp. 1228 - 1237
Endocrinology & Metabolism | Sodium glucose co-transporter 2 (SGLT2) inhibitor | Kidneys | Type 2 diabetes mellitus | Life Sciences & Biomedicine | Science & Technology | Kidney - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Sodium-Glucose Transporter 2 - metabolism | Homeostasis - physiology | Humans | Glucose - metabolism | Diabetes Mellitus, Type 2 - metabolism | Kidney - physiopathology | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Type 2 diabetes | Homeostasis | Glucose metabolism | Glucose | Health aspects | Dextrose | Index Medicus
Journal Article